ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,049.24
      0.88%
      US Tech 100
      21,108.40
      1.14%
      Dow Jones
      44,025.81
      1.24%
      Brent Oil
      78.495
      -0.32%
      Bitcoin
      106,007.30
      -0.16%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Hepion Pharmaceuticals Inc (HEPA) Quote

      Hepion Pharmaceuticals Inc

      Hepion Pharmaceuticals Inc (HEPA)

      NASDAQ
      0.3218
      -0.1472
      (-31.39%)
      Closed January 21 4:00PM
      Delayed by 15 minutes
      0.3196
      -0.0022
      (-0.68%)
      After Hours: 7:36PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.3196
      Bid
      0.3002
      Ask
      0.322
      Volume
      1,664,627
      0.2813 Day's Range 0.44
      0.30 52 Week Range 3.4899
      Market Cap
      2.224M
      Previous Close
      0.469
      Open
      0.44
      Last Trade
      91
      @
      0.3196
      Last Trade Time
      Financial Volume
      $ 538,248
      VWAP
      0.323344
      Average Volume (3m)
      50,807
      Shares Outstanding
      6,958,371
      Dividend Yield
      -
      PE Ratio
      -0.05
      Earnings Per Share (EPS)
      -7.03
      Revenue
      -
      Net Profit
      -48.93M

      About Hepion Pharmaceuticals Inc

      Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.hepion.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HEPA. The last closing price for Hepion Pharmaceuticals was $0.47. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of $ 0.30 to $ 3.4899.

      Hepion Pharmaceuticals currently has 6,958,371 shares outstanding. The market capitalization of Hepion Pharmaceuticals is $3.26 million. Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.05.

      Ask ADVFN Intelligence (AI)

      HEPA Latest News

      More News

      FeaturedLuke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program

      11 hours ago

      Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

      January 13 2025
      Edgar (US Regulatory)

      Form 8-K - Current report

      December 11 2024
      Edgar (US Regulatory)

      Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

      EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...

      December 11 2024
      GlobeNewswire Inc.

      Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

      December 05 2024
      Edgar (US Regulatory)

      Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

      December 02 2024
      Edgar (US Regulatory)

      Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

      Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...

      December 02 2024
      GlobeNewswire Inc.

      Form 425 - Prospectuses and communications, business combinations

      November 21 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 21 2024
      Edgar (US Regulatory)

      Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

      KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

      November 11 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.1734-35.17241379310.4930.52790.31497090.45095935CS
      4-0.1804-36.080.50.73450.31100310.53290816CS
      12-0.3694-53.61393323660.6890.740.3508070.56772791CS
      26-0.7104-68.97087378641.031.030.31112790.75459121CS
      52-1.8104-84.99530516432.133.48990.3830801.14345176CS
      156-20.6804-98.47809523812126.60.320878113.06773626CS
      260-113.6804-99.71964912281141500.390495640.64176001CS

      HEPA - Frequently Asked Questions (FAQ)

      What is the current Hepion Pharmaceuticals share price?
      The current share price of Hepion Pharmaceuticals is $ 0.3196
      How many Hepion Pharmaceuticals shares are in issue?
      Hepion Pharmaceuticals has 6,958,371 shares in issue
      What is the market cap of Hepion Pharmaceuticals?
      The market capitalisation of Hepion Pharmaceuticals is USD 3.26M
      What is the 1 year trading range for Hepion Pharmaceuticals share price?
      Hepion Pharmaceuticals has traded in the range of $ 0.30 to $ 3.4899 during the past year
      What is the PE ratio of Hepion Pharmaceuticals?
      The price to earnings ratio of Hepion Pharmaceuticals is -0.05
      What is the reporting currency for Hepion Pharmaceuticals?
      Hepion Pharmaceuticals reports financial results in USD
      What is the latest annual profit for Hepion Pharmaceuticals?
      The latest annual profit of Hepion Pharmaceuticals is USD -48.93M
      What is the registered address of Hepion Pharmaceuticals?
      The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Hepion Pharmaceuticals website address?
      The website address for Hepion Pharmaceuticals is www.hepion.com
      Which industry sector does Hepion Pharmaceuticals operate in?
      Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ASSTAsset Entities Inc
      $ 0.8998
      (93.71%)
      		262.98M
      DWTXDogwood Therapeutics Inc
      $ 3.18
      (70.05%)
      		24.28M
      USEGUS Energy Corp
      $ 3.74
      (61.21%)
      		107.77M
      DOGZDogness International Corporation
      $ 27.62
      (52.60%)
      		1.93M
      MYNAMynaric AG
      $ 0.6697
      (50.83%)
      		3.72M
      GOEVCanoo Inc
      $ 0.3748
      (-72.24%)
      		41.38M
      SHOTWSafety Shot Inc
      $ 0.1094
      (-47.40%)
      		18.06k
      ORKTOrangeKloud Technology Inc
      $ 0.7068
      (-36.89%)
      		7.48M
      HEPAHepion Pharmaceuticals Inc
      $ 0.3219
      (-31.36%)
      		1.66M
      WNWMeiwu Technology Company Ltd
      $ 0.2681
      (-27.05%)
      		11.02M
      GCTKGlucoTrack Inc
      $ 0.1226
      (44.41%)
      		614.77M
      CRKNCrown Electrokinetics Corporation
      $ 0.1121
      (-10.32%)
      		393.29M
      ASSTAsset Entities Inc
      $ 0.8998
      (93.71%)
      		263.47M
      RIMEAlgorhythm Holdings Inc
      $ 0.034599
      (-16.83%)
      		230.94M
      RGTIRigetti Computing Inc
      $ 13.97
      (42.12%)
      		226.96M

      HEPA Discussion

      View Posts
      willlbone willlbone 8 hours ago
      Trump dump.
      👍️0
      tw0122 tw0122 3 months ago
      HEPA give it a holler .85 + 40%
      👍️0
      blue finch blue finch 5 months ago
      i remember you from vitra
      we all
      made money
      👍️0
      Ruffieruff Ruffieruff 5 months ago
      Yup. Seem to find em all.
      👍️0
      blue finch blue finch 5 months ago
      ugh
      Another scam
      WTF
      👍️0
      Monksdream Monksdream 6 months ago
      HEPA new 52 week low
      👍️0
      Monksdream Monksdream 6 months ago
      HEPA new 52 week low
      👍️0
      Monksdream Monksdream 6 months ago
      HEPA new 52 week low
      👍️0
      Ruffieruff Ruffieruff 6 months ago
      Scam. All shareholders continues to get screwed.
      👍️0
      Monksdream Monksdream 6 months ago
      Whoops, I did it, again
      👍️0
      Awl416 Awl416 6 months ago
      Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement
      👍️0
      Monksdream Monksdream 6 months ago
      HEPA under $2
      👍️0
      Monksdream Monksdream 7 months ago
      HEPA under $2
      👍️0
      Awl416 Awl416 9 months ago
      Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
      👍️0
      Monksdream Monksdream 12 months ago
      HEPA new 52 week low
      👍️0
      Monksdream Monksdream 12 months ago
      HEPA new 52 week low
      👍️0
      Ruffieruff Ruffieruff 2 years ago
      POS
      👍️0
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 2 years ago
      Any thoughts on whether they could see accelerated approval now? results were good and there are no good alternatives.
      👍️0
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 2 years ago
      What if it is a lush partnership instead?
      👍️0
      shurtha2000 shurtha2000 2 years ago
      Thanks
      👍️0
      Disquisition Disquisition 2 years ago
      Absolutely correct, sir
      👍️0
      make it happen make it happen 2 years ago
      Don't forget it's a delinquent stock has failed to meet requirements ie r/s to raise more funds rinse and repeat for at least another 3 years and if one bad thing happens expect a 90% haircut immediately imho
      👍️0
      Disquisition Disquisition 2 years ago
      people DUMPING knowing the OFFERING is imminent…
      👍️0
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 2 years ago
      GOOD CALL: after R/S This could be a moon shot on good top line results
      👍️0
      da_stock_analyst da_stock_analyst 2 years ago
      #HEPA ?? 117% move today! Looking strong and ready for tomorrow! $HEPA
      👍️0
      make it happen make it happen 2 years ago
      R/S, huge double digit negative returns, burning capital, zero Profitability

      Management Effectiveness
      Return on Assets -42.63%
      Return on Equity  -78.41%

      Cash Flow Statement
      Operating Cash Flow -33.05M
      Levered Free Cash Flow -16.86M

      Profitability
      Profit Margin. 0.00%
      Operating Margin 0.00%

      Yahoo

      It is losing/spending more than its market cap. Imho will fade back to singles and dilute. It can't keep operations running without selling shares to share holders.
      👍️0
      Disquisition Disquisition 2 years ago
      Yes (for up to $350 million)

      and Yes (check the latest 10Q - very little cash left on hand)
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      DO THEY HAVE A SHELF OFFERING TO DRAW FROM?

      ARE THEY CURRENTLY IN NEED OF CASH FROM AN OFFERING?

      Message in reply to:
      Offering tonight or tomorrow. Called it
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      GOOD CALL
      after R/S This could be a moon shot on good top line results
      👍️ 1
      Pt3 Pt3 2 years ago
      Call wrong baby ....Biden say No more offering.... inflation is extremely now
      👍️0
      Disquisition Disquisition 2 years ago
      Offering tonight or tomorrow. Called it
      👍️0
      Triple nickle Triple nickle 2 years ago
      Might jus do it
      👍️0
      Triple nickle Triple nickle 2 years ago
      Gotta bust thru 16.40 and hold it
      👍️0
      makinezmoney makinezmoney 2 years ago
      $HEPA : Meeting those PRIMARY ENDPOINTS


      Another MDGL kinda booster about to happen here.... now $15



      GO $HEPA
      👍️0
      Ruffieruff Ruffieruff 2 years ago
      This is not even .80c PS. Whose selling?
      👍️0
      shurtha2000 shurtha2000 2 years ago
      $15.73 building a new base
      👍️0
      Disquisition Disquisition 2 years ago
      DUMPED all my 7zzzz at 16
      👍️0
      shurtha2000 shurtha2000 2 years ago
      Achieves primary and secondary endpoints its all good

      https://finance.yahoo.com/news/hepion-pharmaceuticals-phase-2-altitude-110000500.html
      👍️0
      shurtha2000 shurtha2000 2 years ago
      Will Pre-market trading be suspended ?
      👍️0
      tw0122 tw0122 2 years ago
      830 am
      Monday’s conference call update
      👍️0
      shurtha2000 shurtha2000 2 years ago
      after R/S This could be a moon shot on good top line results
      👍️ 1
      Ruffieruff Ruffieruff 2 years ago
      But it all. Taking knife. We are scammed.
      👍️ 1
      makinezmoney makinezmoney 2 years ago
      $HEPA: So the RS happened........ now $9

      But on a downdip........... will have to get some more if this dips sub $9


      GO $HEPA
      👍️0
      Ruffieruff Ruffieruff 2 years ago
      Your shares look like crap like the rest of us!! Pumper
      👍️ 1
      Ruffieruff Ruffieruff 2 years ago
      Scumbags!!
      👍️ 1
      blue finch blue finch 2 years ago
      I'd consider getting back at .36
      👍️0
      blue finch blue finch 2 years ago
      Why
      👍️0
      Ruffieruff Ruffieruff 2 years ago
      Good thing you dumped this dog.
      👍️0
      Ruffieruff Ruffieruff 2 years ago
      Pumper come back. Where have you been? We need another boost and lecture. Pumper rah rah rah.
      👍️0
      Ruffieruff Ruffieruff 2 years ago
      This is dogchit!!
      👍️0

      Your Recent History

      NASDAQ
      HEPA
      Hepion Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads